mesalamine has been researched along with Pregnancy in 71 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Motherisk Program prospectively enrolled and followed up 165 women exposed to mesalamine during pregnancy, 146 of whom had first trimester exposure." | 9.08 | The safety of mesalamine in human pregnancy: a prospective controlled cohort study. ( Bologa, M; Diav-Citrin, O; Koren, G; Park, YH; Pastuszak, A; Polachek, H; Veerasuntharam, G, 1998) |
| "The Motherisk Program prospectively enrolled and followed up 165 women exposed to mesalamine during pregnancy, 146 of whom had first trimester exposure." | 5.08 | The safety of mesalamine in human pregnancy: a prospective controlled cohort study. ( Bologa, M; Diav-Citrin, O; Koren, G; Park, YH; Pastuszak, A; Polachek, H; Veerasuntharam, G, 1998) |
| " Mesalamine is considered safe in pregnancy, excluding formulations with dibutyl phthalate." | 5.05 | Mesalamine in the Initial Therapy of Ulcerative Colitis. ( Chibbar, R; Moss, AC, 2020) |
| "Non-adherence to mesalamine was underestimated by physicians in pregnant UC patients and contributed to disease relapse and possibly on pregnancy outcomes." | 4.02 | Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes. ( Esaki, M; Fujii, T; Hibi, T; Hokari, R; Ishihara, S; Kitamura, K; Kobayashi, T; Kuji, N; Kunisaki, R; Miura, S; Nagahori, M; Naganuma, M; Nakamura, S; Sakuraba, A; Suzuki, Y; Takashi, K; Watanabe, C; Yamagami, H; Yokoyama, K; Yonezawa, M; Yoshimura, N, 2021) |
| " Because the patient was allergic to mesalazine, adalimumab (ADA) was used as maintenance therapy during pregnancy, following prednisolone as remission induction therapy." | 3.79 | Maintenance of the remission stage of Crohn's disease with adalimumab therapy during pregnancy. ( Ebi, M; Joh, T; Kamiya, T; Katano, T; Kataoka, H; Mizoshita, T; Mori, Y; Ozeki, K; Tanida, S; Tsukamoto, H, 2013) |
| "The drug is useful in the treatment of active ulcerative colitis as well as in preventing relapses of the disease in remission." | 3.75 | Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. ( Peppercorn, MA, 1984) |
| " We, therefore, conduct a randomized and controlled trial to evaluate the efficacy and safety of mesalazine enteric-coated tablets combined with Kangfuxin Liquid (KFX) enema for the child-bearing period female with active UC." | 3.01 | Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial. ( Li, F; Lu, H; Wang, T; Zhang, Q, 2021) |
| " As long-term administration of medications is often necessary, the safety of drug therapy during pregnancy and breast-feeding needs to be considered in daily clinical practice." | 2.50 | IBD medications during pregnancy and lactation. ( Hendel, J; Maxwell, C; Nielsen, OH, 2014) |
| "ulcerative colitis and Crohn's disease), for both active disease and the control of remission." | 2.44 | Drug insight: aminosalicylates for the treatment of IBD. ( Munck, LK; Nielsen, OH, 2007) |
| "Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby." | 2.44 | Pregnancy and breastfeeding in patients with Crohn's disease. ( Felley, C; Froehlich, F; Gonvers, JJ; Juillerat, P; Michetti, P; Mottet, C; Pittet, V; Vader, JP, 2007) |
| "The same drugs are used to treat hemorrhagic rectocolitis (HRC) and Crohn's disease (CD), although the aims are very different." | 2.44 | [Treatment of chronic inflammatory bowel diseases]. ( Lémann, M, 2007) |
| "Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby." | 2.43 | Pregnancy and Crohn's disease. ( Burnand, B; Felley, C; Froehlich, F; Gonvers, JJ; Juillerat, P; Michetti, P; Mottet, C; Vader, JP, 2005) |
| "Crohn's disease is a chronic inflammatory bowel disorder with a relapsing and remitting course." | 2.42 | Maintenance of remission in Crohn's disease: current and emerging therapeutic options. ( Brookes, MJ; Green, JR, 2004) |
| "Women with ulcerative colitis who are pregnant have many concerns, such as the effect of the gestational period on UC, the effect of UC on the pregnancy, and the safety of drugs used to control the disease." | 2.40 | [Ulcerative colitis and pregnancy]. ( Ida, A; Koyama, K, 1999) |
| "Pentasa-related adverse events were recorded from 1 January 1993 to 31 December 1994." | 2.39 | Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France. ( Devaux, C; Le Lu, M; Marteau, P; Nelet, F, 1996) |
| "Paternal and maternal use of 5-ASA was safe across offspring outcomes; none of the findings reached statistical significance." | 1.72 | The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study. ( Friedman, S; Kjeldsen, J; Nielsen, J; Nørgård, BM, 2022) |
| "A pregnant woman with severe ulcerative colitis was treated with a dose of mesalazine 4,000 mg/day from early gestation to delivery." | 1.62 | Maternal mesalazine-induced neonatal gastrointestinal bleeding. ( Kuboi, T; Nii, K; Okada, H; Okazaki, K, 2021) |
| "Although severe flare of ulcerative colitis (UC) is uncommon, it significantly increases the risk of preterm delivery, low birth weight and other adverse fetal outcomes." | 1.46 | Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem. ( Markovic, S; Protic, M; Tarabar, D, 2017) |
| "Disease relapse was measured at each visit." | 1.43 | The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies. ( de Lima-Karagiannis, A; van der Woude, CJ; Zelinkova-Detkova, Z, 2016) |
| "The prevalence rate of Crohn's disease and ulcerative colitis in our male infertile patients was 163 per 100,000 men and 490 per 100,000 men, respectively." | 1.40 | Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility. ( Arai, G; Iwahata, T; Kobori, Y; Okada, H; Shin, T; Soh, S; Suzuki, K; Yagi, H, 2014) |
| "Moderate-to-severe active extensive ulcerative colitis, unresponsive to mesalazine at 3." | 1.33 | Combined oral and topical mesalazine treatment for extensive ulcerative colitis. ( Cheifetz, AS; Moss, AC; Peppercorn, MA, 2006) |
| "Will pregnancy affect the disease? 4." | 1.30 | [Crohn's disease and pregnancy. A case report]. ( Gudiño Molina, FJ; Jinich Brook, H; Montiel-Jarquin, A; Rodríguez Torres, LF, 1998) |
| "We report the case of a man with ulcerative colitis in whom infertility and a markedly abnormal SPA were demonstrated while he was taking sulfasalazine." | 1.27 | Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. ( Batzer, FR; Chatzinoff, M; Corson, SL; Friedman, LS; Guarino, JM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (7.04) | 18.7374 |
| 1990's | 16 (22.54) | 18.2507 |
| 2000's | 28 (39.44) | 29.6817 |
| 2010's | 13 (18.31) | 24.3611 |
| 2020's | 9 (12.68) | 2.80 |
| Authors | Studies |
|---|---|
| Nørgård, BM | 1 |
| Friedman, S | 2 |
| Kjeldsen, J | 1 |
| Nielsen, J | 1 |
| Avni-Biron, I | 1 |
| Mishael, T | 1 |
| Zittan, E | 1 |
| Livne-Margolin, M | 1 |
| Zinger, A | 1 |
| Tzadok, R | 1 |
| Goldenberg, R | 1 |
| Kopylov, U | 1 |
| Ron, Y | 1 |
| Hadar, E | 1 |
| Helman, S | 1 |
| Granovsky, SG | 1 |
| Ollech, JE | 1 |
| Arazi, A | 1 |
| Farkash, R | 1 |
| Pauker, MH | 1 |
| Yanai, H | 1 |
| Dotan, I | 1 |
| Shitrit, AB | 1 |
| Bennett, A | 1 |
| Horst, S | 1 |
| Lee, S | 1 |
| Seow, CH | 1 |
| Adhikari, K | 1 |
| Metcalfe, A | 1 |
| Watanabe, C | 1 |
| Nagahori, M | 1 |
| Fujii, T | 1 |
| Yokoyama, K | 1 |
| Yoshimura, N | 1 |
| Kobayashi, T | 1 |
| Yamagami, H | 1 |
| Kitamura, K | 1 |
| Takashi, K | 1 |
| Nakamura, S | 1 |
| Naganuma, M | 1 |
| Ishihara, S | 1 |
| Esaki, M | 1 |
| Yonezawa, M | 1 |
| Kunisaki, R | 1 |
| Sakuraba, A | 1 |
| Kuji, N | 1 |
| Miura, S | 1 |
| Hibi, T | 1 |
| Suzuki, Y | 1 |
| Hokari, R | 1 |
| Chibbar, R | 1 |
| Moss, AC | 2 |
| Wang, T | 1 |
| Lu, H | 1 |
| Li, F | 1 |
| Zhang, Q | 1 |
| Céruti, H | 1 |
| Kayem, G | 1 |
| Guilbaud, L | 1 |
| Dussaux, C | 1 |
| Gervais, A | 1 |
| Beaufrère, A | 1 |
| Coffin, B | 1 |
| Mandelbrot, L | 1 |
| Maisonneuve, E | 1 |
| Nii, K | 1 |
| Okazaki, K | 1 |
| Okada, H | 3 |
| Kuboi, T | 1 |
| Ek, S | 1 |
| Rosenborg, S | 1 |
| Mizoshita, T | 1 |
| Tanida, S | 1 |
| Tsukamoto, H | 1 |
| Ozeki, K | 1 |
| Katano, T | 1 |
| Ebi, M | 1 |
| Mori, Y | 1 |
| Kataoka, H | 1 |
| Kamiya, T | 1 |
| Joh, T | 1 |
| Nielsen, OH | 2 |
| Maxwell, C | 1 |
| Hendel, J | 1 |
| Ban, L | 1 |
| Tata, LJ | 1 |
| Fiaschi, L | 1 |
| Card, T | 1 |
| Källén, B | 1 |
| Shin, T | 1 |
| Kobori, Y | 1 |
| Suzuki, K | 2 |
| Iwahata, T | 1 |
| Yagi, H | 1 |
| Soh, S | 1 |
| Arai, G | 1 |
| D'Ovidio, V | 1 |
| Meo, D | 1 |
| Gozer, M | 1 |
| Bazuro, ME | 1 |
| Vernia, P | 1 |
| de Lima-Karagiannis, A | 1 |
| Zelinkova-Detkova, Z | 1 |
| van der Woude, CJ | 1 |
| Protic, M | 1 |
| Markovic, S | 1 |
| Tarabar, D | 1 |
| Moum, B | 1 |
| Hernández-Díaz, S | 2 |
| Mitchell, AA | 2 |
| Kelley, KE | 2 |
| Calafat, AM | 2 |
| Hauser, R | 2 |
| Saha, S | 1 |
| Esposti, SD | 1 |
| Mountifield, RE | 1 |
| Prosser, R | 1 |
| Bampton, P | 1 |
| Muller, K | 1 |
| Andrews, JM | 1 |
| Ye, BD | 1 |
| Yang, SK | 1 |
| Shin, SJ | 1 |
| Lee, KM | 1 |
| Jang, BI | 1 |
| Cheon, JH | 1 |
| Choi, CH | 1 |
| Kim, YH | 1 |
| Lee, H | 1 |
| Su, YC | 1 |
| Jang, YW | 1 |
| Park, YS | 1 |
| Kim, SH | 1 |
| Jo, YJ | 1 |
| Jo, YK | 1 |
| Ahn, SB | 1 |
| Seo, YS | 1 |
| Hong, YO | 1 |
| Tanaka, H | 1 |
| Katoh, D | 1 |
| Shimizu, M | 1 |
| Ohno, T | 1 |
| Tanaka, S | 1 |
| Kanda, Y | 1 |
| Nørgård, B | 2 |
| Fonager, K | 1 |
| Pedersen, L | 2 |
| Jacobsen, BA | 1 |
| Sørensen, HT | 2 |
| Fleig, WE | 1 |
| Fujimaru, K | 1 |
| Taneichi, H | 1 |
| Matsubara, K | 1 |
| Takebe, N | 1 |
| Ishida, W | 1 |
| Kaneko, Y | 1 |
| Sawada, A | 1 |
| Fukusima, A | 1 |
| Syouji, T | 1 |
| Isurugi, C | 1 |
| Kawahara, T | 1 |
| Seki, H | 1 |
| Oikawa, N | 1 |
| Brookes, MJ | 1 |
| Green, JR | 1 |
| Mottet, C | 2 |
| Juillerat, P | 2 |
| Gonvers, JJ | 2 |
| Froehlich, F | 2 |
| Burnand, B | 1 |
| Vader, JP | 2 |
| Michetti, P | 3 |
| Felley, C | 2 |
| Marteau, P | 6 |
| Seksik, P | 1 |
| Couve, S | 1 |
| Jian, R | 1 |
| Caprilli, R | 1 |
| Gassull, MA | 1 |
| Escher, JC | 1 |
| Moser, G | 1 |
| Munkholm, P | 1 |
| Forbes, A | 1 |
| Hommes, DW | 1 |
| Lochs, H | 1 |
| Angelucci, E | 1 |
| Cocco, A | 1 |
| Vucelic, B | 1 |
| Hildebrand, H | 1 |
| Kolacek, S | 1 |
| Riis, L | 1 |
| Lukas, M | 1 |
| de Franchis, R | 1 |
| Hamilton, M | 1 |
| Jantschek, G | 1 |
| O'Morain, C | 1 |
| Anwar, MM | 1 |
| Freitas, JL | 1 |
| Mouzas, IA | 1 |
| Baert, F | 1 |
| Mitchell, R | 1 |
| Hawkey, CJ | 1 |
| Cheifetz, AS | 1 |
| Peppercorn, MA | 2 |
| Makidono, C | 1 |
| Takenaka, R | 1 |
| Hiraoka, S | 1 |
| Fujiwara, A | 1 |
| Kato, J | 1 |
| Kawahara, Y | 1 |
| Kawamoto, H | 1 |
| Mizuno, M | 1 |
| Shiratori, Y | 1 |
| Menzies, O | 1 |
| Colls, B | 1 |
| Munck, LK | 1 |
| Christensen, LA | 3 |
| Gottesleben, F | 1 |
| Moffatt, DC | 1 |
| Bernstein, CN | 1 |
| Pittet, V | 1 |
| Rahimi, R | 1 |
| Nikfar, S | 1 |
| Rezaie, A | 1 |
| Abdollahi, M | 1 |
| Lémann, M | 2 |
| Colombel, JF | 1 |
| Brabant, G | 1 |
| Gubler, MC | 1 |
| Locquet, A | 1 |
| Comes, MC | 1 |
| Dehennault, M | 1 |
| Delcroix, M | 1 |
| Devaux, CB | 1 |
| Rasmussen, SN | 2 |
| Hansen, SH | 2 |
| Trallori, G | 1 |
| d'Albasio, G | 1 |
| Bardazzi, G | 1 |
| Bonanomi, AG | 1 |
| Amorosi, A | 1 |
| Del Carlo, P | 1 |
| Palli, D | 1 |
| Galli, M | 1 |
| Pacini, F | 1 |
| Nelet, F | 1 |
| Le Lu, M | 1 |
| Devaux, C | 1 |
| Cellier, C | 1 |
| Bell, CM | 1 |
| Habal, FM | 1 |
| Diav-Citrin, O | 1 |
| Park, YH | 1 |
| Veerasuntharam, G | 1 |
| Polachek, H | 1 |
| Bologa, M | 1 |
| Pastuszak, A | 1 |
| Koren, G | 1 |
| Botoman, VA | 1 |
| Bonner, GF | 1 |
| Botoman, DA | 1 |
| Gudiño Molina, FJ | 1 |
| Jinich Brook, H | 1 |
| Montiel-Jarquin, A | 1 |
| Rodríguez Torres, LF | 1 |
| Tennenbaum, R | 2 |
| Elefant, E | 2 |
| Cosnes, J | 2 |
| Sachar, D | 1 |
| Saubermann, LJ | 1 |
| Wolf, JL | 1 |
| Rambaud, JC | 1 |
| Modigliani, R | 1 |
| Gendre, JP | 1 |
| Cissoko, H | 1 |
| Jonville-Béra, AP | 1 |
| Lenain, H | 1 |
| Rivière, MF | 1 |
| Saugier, J | 1 |
| Casanova, JL | 1 |
| Autret-Leca, E | 1 |
| Ida, A | 1 |
| Koyama, K | 1 |
| Stein, RB | 1 |
| Hanauer, SB | 1 |
| Katz, JA | 1 |
| Pore, G | 1 |
| Ward, VM | 1 |
| Dua, S | 1 |
| Morrison, GA | 1 |
| Banatwala, N | 1 |
| Shimamoto, M | 1 |
| Takewaki, S | 1 |
| Sakuraoka, S | 1 |
| Nagasawa, T | 1 |
| Kuroiwa, K | 1 |
| Kodama, O | 1 |
| Akatsuka, T | 1 |
| Ambrosius Christensen, L | 1 |
| Bondesen, S | 1 |
| Hvidberg, EF | 1 |
| Chatzinoff, M | 1 |
| Guarino, JM | 1 |
| Corson, SL | 1 |
| Batzer, FR | 1 |
| Friedman, LS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Counseling to Optimize Medication Adherence in Expectant Mothers With Inflammatory Bowel Disease (COACH-IBD)[NCT03091309] | 220 participants (Anticipated) | Interventional | 2017-10-01 | Recruiting | |||
| Human Exposure to Bisphenol A, Phthalates and Fertility, Pregnancy Outcomes.[NCT00011713] | 1,474 participants (Actual) | Observational | 1999-10-31 | Completed | |||
| The Effect of Sulfasalazine on CRH Levels in Pregnant Women With a History of Pre-Term Birth: A Randomized Controlled Trial[NCT05703425] | Phase 2 | 50 participants (Anticipated) | Interventional | 2023-03-01 | Recruiting | ||
| Synbiotic Treatment in Crohn's Disease Patients[NCT00305409] | 50 participants (Anticipated) | Interventional | 2006-06-30 | Completed | |||
| MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392] | 181 participants (Anticipated) | Interventional | 2020-07-28 | Recruiting | |||
| A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391] | 100 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for mesalamine and Pregnancy
| Article | Year |
|---|---|
Mesalamine in the Initial Therapy of Ulcerative Colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dibutyl Phthalate; Drug Compounding; E | 2020 |
IBD medications during pregnancy and lactation.
Topics: Ciprofloxacin; Female; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Lactation; Mesalamine; | 2014 |
Reproductive issues in inflammatory bowel disease.
Topics: Adaptation, Psychological; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathio | 2009 |
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroi | 2009 |
Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory A | 2004 |
Pregnancy and Crohn's disease.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy | 2005 |
Drug insight: aminosalicylates for the treatment of IBD.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Colitis, Ulcerative; | 2007 |
Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antidiarrheals; Fe | 2007 |
Pregnancy and breastfeeding in patients with Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Breast Feeding; Crohn Disease; Drug | 2007 |
Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
[Treatment of chronic inflammatory bowel diseases].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Ste | 2007 |
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
Topics: Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug In | 1984 |
Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Female; France; Humans; Mesalamine; P | 1996 |
[Side effects of 5-aminosalicylic acid].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Inflammatory Bowel Di | 1997 |
Management of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ul | 1998 |
[Ulcerative colitis and pregnancy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Fertility; Humans; Immu | 1999 |
5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Feces; Female; Humans; Injections, In | 2000 |
Comparative tolerability of treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Gas | 2000 |
Inflammatory bowel disease and pregnancy.
Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Female; Fert | 2001 |
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Drug Combinations; Dr | 1985 |
4 trials available for mesalamine and Pregnancy
| Article | Year |
|---|---|
Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Enema; Fem | 2021 |
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
Topics: Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug In | 1984 |
5-Aminosalicylic acid in pregnancy: clinical report.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Female; Fetus; Humans; Mesalamine; Pregnancy; Preg | 1994 |
The safety of mesalamine in human pregnancy: a prospective controlled cohort study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Female; Humans; Inflammatory Bowel D | 1998 |
48 other studies available for mesalamine and Pregnancy
| Article | Year |
|---|---|
The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.
Topics: Child; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Fathers; Female; Humans; Infant, Newborn; | 2022 |
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study.
Topics: Biological Products; Chronic Disease; Female; Humans; Infant, Newborn; Inflammatory Bowel Diseases; | 2022 |
Editorial: maternal and paternal 5-aminosalicylic acid use-safe in conception and pregnancy.
Topics: Female; Fertilization; Humans; Mesalamine; Pregnancy; Pregnancy Complications | 2022 |
Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.
Topics: Adult; Biological Factors; Biological Therapy; Canada; Drug Prescriptions; Female; Humans; Inflammat | 2020 |
Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; | 2021 |
Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series.
Topics: Adult; Azathioprine; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis, Intrahepatic; C | 2021 |
Maternal mesalazine-induced neonatal gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Gast | 2021 |
Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report.
Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Erythrocyte Transfusion; Female; Fetal Diseases; Hu | 2017 |
Maintenance of the remission stage of Crohn's disease with adalimumab therapy during pregnancy.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Blood Component Removal; Colonoscopy; Combined | 2013 |
Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Congenital Abnormali | 2014 |
Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Infant, | 2014 |
Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Fertility; Gastrointestinal Ag | 2014 |
Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Combined Modality Therapy; Fema | 2015 |
The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis, Ulce | 2016 |
Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem.
Topics: Adrenal Cortex Hormones; Adult; Colitis, Ulcerative; Disease Progression; Female; Humans; Infliximab | 2017 |
Which are the 5-ASA compound side effects and how is it possible to avoid them?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; | 2008 |
Medications as a potential source of exposure to phthalates in the U.S. population.
Topics: Adolescent; Adult; Data Collection; Didanosine; Environmental Exposure; Female; Humans; Male; Mesala | 2009 |
Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cross-Sectional Studies; Fem | 2010 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn | 2012 |
Medications as a potential source of exposure to phthalates among women of childbearing age.
Topics: Adolescent; Adult; Amitriptyline; Drug Utilization; Environmental Exposure; Female; Humans; Mesalami | 2013 |
[A case of Crohn's disease having normal delivery after infliximab treatment during early pregnancy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Capsule Endoscopy; Colon, Si | 2013 |
[A case of neonatal severe hypereosinophilia associated with mesalazine administered during pregnancy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Hypereosinophilic Synd | 2002 |
Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis | 2003 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2003 |
[Successful delivery in case of pregnancy with type 1 diabetes mellitus complicated by ulcerative colitis ].
Topics: Adult; Betamethasone; Colitis, Ulcerative; Diabetes Mellitus, Type 1; Diet, Diabetic; Female; Humans | 2003 |
Safety of high doses of mesalazine during pregnancy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Pr | 2005 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colit | 2006 |
Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Combined Modality Therapy; Fema | 2006 |
Colitis and bronchiolitis obliterans organising pneumonia--the treatment or the disease?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bronchiolitis Obliterans; Colitis, Ulcerative; Femal | 2006 |
Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Congenital Abnorma | 2007 |
[Crohn disease, exacerbated during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Budesonide; Crohn Disease; Diagnosis, Differential; Drug Therapy, C | 2007 |
Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?
Topics: Adult; Aminosalicylic Acids; Crohn Disease; Female; Fetus; Humans; Infant; Kidney Diseases; Male; Me | 1994 |
Mesalazine during pregnancy.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Infant, Newb | 1994 |
Disposition of 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid in fetal and maternal body fluids during treatment with different 5-aminosalicylic acid preparations.
Topics: Aminosalicylic Acids; Drug Monitoring; Female; Fetal Blood; Fetus; Humans; Inflammatory Bowel Diseas | 1994 |
Safety of topical 5-aminosalicylic acid in pregnancy.
Topics: Abnormalities, Drug-Induced; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal | 1997 |
[Crohn's disease and pregnancy. A case report].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Crohn Disease; Female; Humans; Infant, Newb | 1998 |
Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Drug Administration Schedul | 1998 |
Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Birth Weight; Case-Cont | 1998 |
Mesalamine: safe at first look.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Female; Humans; Inflammatory Bowel Diseases | 1999 |
[Pregnancy outcome in inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; | 1999 |
[Agranulocytosis and transitory immune deficiency after fetal exposure to azathioprine and mesalazine].
Topics: Adult; Agammaglobulinemia; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C | 1999 |
Management of inflammatory bowel disease during pregnancy and nursing.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Breast Feeding; Ce | 2001 |
Oro-facial granulomatosis: a laryngeal presentation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Female; Granuloma, Laryngeal; Huma | 2001 |
Balsalazide disodium.
Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Drug Interactions; Female; Humans; Mal | 2002 |
Use of L-leucyl-3-carboxy-4-hydroxyanilide as substrate for determining the activity of microsomal aminopeptidase in serum.
Topics: Aminopeptidases; Aminosalicylic Acids; Anilides; Biliary Tract Diseases; CD13 Antigens; Chromogenic | 1985 |
Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Body Fluids; Female; Fetus; Humans; Maternal-Fetal Exchange; Mesalamine | 1987 |
Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Enema; Female; Humans; Infant, Newborn; Infertilit | 1988 |